Volume 19, Issue 5 pp. 699-700

Transient response of cardiac angiosarcoma to paclitaxel

E. CASTILLA MD

Corresponding Author

E. CASTILLA MD

Servicio de Cardiología, Hospital Clínico Universitario, Zaragoza, Spain

D.E. Castilla, Servicio de Cardiologia, Hospital Clínico Universitario, Avda. San Juan Bosco, 15. 50009. Zaragoza, Spain (e-mail: [email protected]). Search for more papers by this author
I. PASCUAL MD, PHD

I. PASCUAL MD, PHD

Servicio de Cardiología, Hospital Clínico Universitario, Zaragoza, Spain

Search for more papers by this author
F. RONCALÉS MD

F. RONCALÉS MD

Servicio de Cardiología, Hospital Clínico Universitario, Zaragoza, Spain

Search for more papers by this author
E. AGUIRRE MD

E. AGUIRRE MD

Servicio de Oncología Médica, Hospital Clínico Universitario, Zaragoza

Search for more papers by this author
A. DEL RÍO MD, PHD

A. DEL RÍO MD, PHD

Servicio de Cardiología, Hospital Clínico Universitario, Zaragoza, Spain

Search for more papers by this author
First published: 13 August 2010
Citations: 7

Abstract

CASTILLA E., PASCUAL I., RONCALÉS F., AGUIRRE E. & RÍO A. DEL (2010) European Journal of Cancer Care19, 699–700

Transient response of cardiac angiosarcoma to paclitaxel

Malignant tumours of the heart are a group of tumours with low incidence but very high mortality. Delays in diagnosis are common because of their multiple forms of presentation, and 80% present with metastases, further reducing the possibility for cure. We present here the case of a patient with primary cardiac angiosarcoma that highlights the misdiagnosis at clinical presentation, current diagnostic modalities and a possible new treatment using paclitaxel for cardiac angiosarcoma.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.